<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02775422</url>
  </required_header>
  <id_info>
    <org_study_id>2014/08</org_study_id>
    <secondary_id>2014-A00707-40</secondary_id>
    <nct_id>NCT02775422</nct_id>
  </id_info>
  <brief_title>Comparison of Serological Test s for the Virus Chicken Pox Virus (VZV) and Correlation With the Patient's Memory of the Infection or Vaccination</brief_title>
  <acronym>VARI-IMM</acronym>
  <official_title>Comparison of Serological Tests for the Varicella-zoster Virus and Correlation With the Memory of the Infection or Vaccination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of the sensibility and specificity of 3 different serological tests and evaluation
      of chicken pox immunity in pregnant women.

      Secondary goals :

        -  Correlation memory / Immunity;

        -  Prevalence of VZV immunity in pregnant women;

        -  Evaluation of cellular and humoral immunity in cases with discrepancy between tests or
           between test and memory;

        -  Evaluation of acceptability of vaccination in the post partum period in non immune
           patients.

      Methods Not randomized prospective study,

      Number of patients : 400 Duration : 36 months Inclusion criteria : pregnant women &gt;18years
      old, agree to participate (written consent) Exclusion criteria: auto immune disease, HIV +,
      grafted patients
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate sensitivity and specificity in negative and dubious zone for the assessment of the serology of anti VZV immunity</measure>
    <time_frame>35 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>frequency of immunity detecting depending on whether the patient remember having varicella, have been in contact with next of kin with varicella or been vaccinated against varicella or not</measure>
    <time_frame>up to 35 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of women accepting the vaccination in case of negative history</measure>
    <time_frame>day during the first visit</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Pregnant women</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pregnant women</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Serological Test s for the Virus Chicken Pox Virus</intervention_name>
    <arm_group_label>Pregnant women</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women aged over 18

          -  Affiliated to a social protection scheme or women benefiting from such a regime

          -  Women who gived a writing consent

        Exclusion Criteria:

          -  Women with a maternal disease: autoimmune disease (systemic lupus erythematosus,
             antiphospholipid syndrome, insulin dependent diabetes, autoimmune thyroiditis ..), it
             takes an immunosuppressive treatment or not.

          -  HIV-positive women

          -  Garfted women whatever organ
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier Picone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service Gynécologie Hopital Foch</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivier Picone, MD</last_name>
    <phone>+33(0)146252974</phone>
    <email>o.picone@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Picone, MD</last_name>
      <phone>+33(0)146252974</phone>
      <email>o.picone@hopital-foch.org</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>LAFORET EG, LYNCH CL Jr. Multiple congenital defects following maternal varicella; report of a case. N Engl J Med. 1947 Apr 10;236(15):534-7. doi: 10.1056/NEJM194704102361504.</citation>
    <PMID>20293114</PMID>
  </reference>
  <reference>
    <citation>Alkalay AL, Pomerance JJ, Rimoin DL. Fetal varicella syndrome. J Pediatr. 1987 Sep;111(3):320-3.</citation>
    <PMID>3625399</PMID>
  </reference>
  <reference>
    <citation>SAUERBREI A. Fetales varizellen syndrom. Monatsschr kinderheiledkd 2003;151:209-213.</citation>
  </reference>
  <reference>
    <citation>Miller E, Cradock-Watson JE, Ridehalgh MK. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet. 1989 Aug 12;2(8659):371-3.</citation>
    <PMID>2569560</PMID>
  </reference>
  <reference>
    <citation>ENDERS G. Varicella and herpes zoster in pregnancy and the newborn. . Varicella-zoster virus and clinical management. Arvin AM and Gershon AA, eds; UK: Cambridge University Press 2000:317-347.</citation>
  </reference>
  <reference>
    <citation>MIRLESSE V. Varicelle et grossesse. Les virus transmissibles de la mère à l'enfant. Denis F. Ed John Libey Eurotext, In Montrouge 1999:252-269.</citation>
  </reference>
  <reference>
    <citation>Khoshnood B, Debruyne M, Lançon F, Emery C, Fagnani F, Durand I, Floret D. Seroprevalence of varicella in the French population. Pediatr Infect Dis J. 2006 Jan;25(1):41-4.</citation>
    <PMID>16395101</PMID>
  </reference>
  <reference>
    <citation>Wu MF, Yang YW, Lin WY, Chang CY, Soon MS, Liu CE. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection. J Hosp Infect. 2012 Feb;80(2):162-7. doi: 10.1016/j.jhin.2011.11.011. Epub 2011 Dec 19.</citation>
    <PMID>22188630</PMID>
  </reference>
  <reference>
    <citation>Vandersmissen G, Moens G, Vranckx R, de Schryver A, Jacques P. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study. Occup Environ Med. 2000 Sep;57(9):621-6.</citation>
    <PMID>10935943</PMID>
  </reference>
  <reference>
    <citation>Alp E, Cevahir F, Gökahmetoglu S, Demiraslan H, Doganay M. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save? J Infect Public Health. 2012 Apr;5(2):127-32. doi: 10.1016/j.jiph.2011.11.003. Epub 2012 Jan 18.</citation>
    <PMID>22541258</PMID>
  </reference>
  <reference>
    <citation>Almuneef M, Memish ZA, Abbas ME, Balkhy HH. Screening healthcare workers for varicella-zoster virus: can we trust the history? Infect Control Hosp Epidemiol. 2004 Jul;25(7):595-8.</citation>
    <PMID>15301033</PMID>
  </reference>
  <reference>
    <citation>Saadatian-Elahi M, Mekki Y, Del Signore C, Lina B, Derrough T, Caulin E, Thierry J, Vanhems P. Seroprevalence of varicella antibodies among pregnant women in Lyon-France. Eur J Epidemiol. 2007;22(6):405-9. Epub 2007 May 30.</citation>
    <PMID>17534728</PMID>
  </reference>
  <reference>
    <citation>Reignier F, Romanò L, Thiry N, Beutels P, Van Damme P, Fau C, Gaspard C, Mamoux V, Zanetti A, Floret D. [Varicella-zoster virus seroprevalence in nursery and day-care workers in Lyon (France)]. Med Mal Infect. 2005 Apr;35(4):192-6. French.</citation>
    <PMID>15914287</PMID>
  </reference>
  <reference>
    <citation>Dashraath P, Ong ES, Lee VJ. Seroepidemiology of varicella and the reliability of a self-reported history of varicella infection in Singapore military recruits. Ann Acad Med Singapore. 2007 Aug;36(8):636-41.</citation>
    <PMID>17767333</PMID>
  </reference>
  <reference>
    <citation>Fung LW, Lao TT, Suen SS, Chan OK, Lau TK, Ngai KL, Chan PK, Leung TY. Seroprevalence of varicella zoster virus among pregnant women in Hong Kong: comparison with self-reported history. Vaccine. 2011 Oct 26;29(46):8186-8. doi: 10.1016/j.vaccine.2011.08.090. Epub 2011 Sep 10.</citation>
    <PMID>21911021</PMID>
  </reference>
  <reference>
    <citation>Pourahmad M, Davami MH, Jahromi AR. Evaluation of anti-varicella antibody in young women before their marriage: A sero-epidemiologic study in Iran. J Clin Virol. 2010 Aug;48(4):260-3. doi: 10.1016/j.jcv.2010.04.015. Epub 2010 Jun 9.</citation>
    <PMID>20538515</PMID>
  </reference>
  <reference>
    <citation>Perella D, Fiks AG, Jumaan A, Robinson D, Gargiullo P, Pletcher J, Forke CM, Schmid DS, Renwick M, Mankodi F, Watson B, Spain CV. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era. Pediatrics. 2009 May;123(5):e820-8. doi: 10.1542/peds.2008-3310. Erratum in: Pediatrics. 2009 Aug;124(2):846.</citation>
    <PMID>19403475</PMID>
  </reference>
  <reference>
    <citation>Koturoglu G, Kurugol Z, Turkoglu E. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults. Paediatr Perinat Epidemiol. 2011 Jul;25(4):388-93. doi: 10.1111/j.1365-3016.2010.01180.x. Epub 2011 Apr 3.</citation>
    <PMID>21649681</PMID>
  </reference>
  <reference>
    <citation>Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 1994 Jun 18;343(8912):1548-51.</citation>
    <PMID>7802767</PMID>
  </reference>
  <reference>
    <citation>Breuer J, Schmid DS, Gershon AA. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella. J Infect Dis. 2008 Mar 1;197 Suppl 2:S147-51. doi: 10.1086/529448. Review.</citation>
    <PMID>18419389</PMID>
  </reference>
  <reference>
    <citation>Maple PA, Rathod P, Smit E, Gray J, Brown D, Boxall EH. Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay. J Clin Virol. 2009 Jan;44(1):9-14. doi: 10.1016/j.jcv.2008.08.012. Epub 2008 Sep 27.</citation>
    <PMID>18823815</PMID>
  </reference>
  <reference>
    <citation>Sauerbrei A, Schäfler A, Hofmann J, Schacke M, Gruhn B, Wutzler P. Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test. Clin Vaccine Immunol. 2012 Aug;19(8):1261-8. doi: 10.1128/CVI.00183-12. Epub 2012 Jun 20.</citation>
    <PMID>22718131</PMID>
  </reference>
  <reference>
    <citation>Tischer A, Gassner M, Richard JL, Suter-Riniker F, Mankertz A, Heininger U. Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunofluorescence and plaque neutralisation tests. J Clin Virol. 2007 Mar;38(3):204-9. Epub 2007 Feb 7.</citation>
    <PMID>17289430</PMID>
  </reference>
  <reference>
    <citation>Mancuso JD, Krauss MR, Audet S, Beeler JA. ELISA underestimates measles antibody seroprevalence in US military recruits. Vaccine. 2008 Sep 8;26(38):4877-8. doi: 10.1016/j.vaccine.2008.06.028. Epub 2008 Jun 27.</citation>
    <PMID>18586062</PMID>
  </reference>
  <reference>
    <citation>Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, Maupin TJ, Goldman GS, Tabony LJ, Brodovicz KG, Jumaan AO, Wharton M. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002 Feb 6;287(5):606-11.</citation>
    <PMID>11829699</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2016</study_first_submitted>
  <study_first_submitted_qc>May 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 17, 2016</study_first_posted>
  <last_update_submitted>January 31, 2017</last_update_submitted>
  <last_update_submitted_qc>January 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

